{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:07:35Z","timestamp":1790687255267,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002329","name":"Bundesamt f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P4P4PM_194449"],"award-info":[{"award-number":["P4P4PM_194449"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vancomycin resistant enterococci (VRE) are on the rise in many European hospitals. In 2018, Switzerland experienced its largest nosocomial VRE outbreak. The national center for infection prevention (Swissnoso) elaborated recommendations for controlling this outbreak and published guidelines to prevent epidemic and endemic VRE spread. The primary goal of this study was to evaluate adherence to this new guideline and its potential impact on the VRE epidemiology in Swiss acute care hospitals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In March 2020, Swissnoso distributed a survey among all Swiss acute care hospitals. The level of adherence as well as changes of infection prevention and control (IPC) strategies in the years 2018 and 2019 after publication of the national guidelines were asked along with an inventory on VRE surveillance and outbreaks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data of 97\/146 (66%) participants were available, representing 81.6% of all acute care beds operated in Switzerland in 2019. The vast majority\u201472\/81 (88%) responding hospitals\u2014have entirely or largely adopted our new national guideline. 38\/51 (74.5%) hospitals which experienced VRE cases were significantly more likely to have changed their IPC strategies than those 19\/38 (50%) hospitals without VRE cases <jats:italic>p<\/jats:italic>\u2009=\u20090.017). The new IPC guidelines included (1) introduction of targeted admission screening in 89.5%, (2) screening of close contacts of VRE cases in 56%, and (3) contact precaution for suspected VRE cases 58% of these hospitals. 52 (54%) hospitals reported 569 new VRE cases in 2018 including 14 bacteremia, and 472 new cases in 2019 with 10 bacteremia. The ten largest outbreaks encountered between 2018 and 2019 included 671 VRE cases, of which most (93.4%) consisted of colonization events, 29 (4.3%) infections and 15 (2.2%) bacteremia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Wide adoption of this VRE control guideline seemed to have a positive effect on VRE containment in Swiss acute care hospitals over two years, even if its long-term impact on the VRE epidemiology remains to be evaluated. Broad dissemination and strict implementation of a uniform national guideline may therefore serve as model for other countries to fight VRE epidemics on a national level.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01051-9","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:03:54Z","timestamp":1643367834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-4035","authenticated-orcid":false,"given":"Danielle","family":"Vuichard-Gysin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Sommerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Buetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Piezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Gardiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for Swissnoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"1051_CR1","volume-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net). Annual epidemiological report 2019","author":"European Centre for Disease Prevention and Control","year":"2020","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net). Annual epidemiological report 2019. ECDC; 2020."},{"issue":"29","key":"1051_CR2","doi-asserted-by":"publisher","first-page":"1800351","DOI":"10.2807\/1560-7917.ES.2018.23.29.1800351","volume":"23","author":"N Wassilew","year":"2018","unstructured":"Wassilew N, Seth-Smith HM, Rolli E, Fietze Y, Casanova C, Fuhrer U, et al. Outbreak of vancomycin-resistant Enterococcus faecium clone ST796, Switzerland, December 2017 to April 2018. Euro Surveill. 2018;23(29):1800351.","journal-title":"Euro Surveill"},{"key":"1051_CR3","doi-asserted-by":"publisher","unstructured":"Vuichard-Gysin D, Harbarth S, Troillet N, Widmer A, Masserey V, Gardiol C, et al. Successful collaboration between Swissnoso and the Federeal Office of Public Health during a national vancomycin resistant enterococcus faecium outbreak. Abstracts from the 5th International Conference on Prevention & Infection Control (ICPIC 2019). Antimicrob Resist Infect Control 8:148; 2019. https:\/\/doi.org\/10.1186\/s13756-019-0567-6.","DOI":"10.1186\/s13756-019-0567-6"},{"key":"1051_CR4","unstructured":"Revision der Verordnung des EDI \u00fcber die Meldung von Beobachtungen \u00fcbertragbarer krankheiten des Menschen: Wichtigste Anpassung per 1. January 2020, S. 10. BAG-Bulletin 51\/2019. https:\/\/www.bag.admin.ch\/bag\/de\/home\/das-bag\/publikationen\/periodika\/bag-bulletin.html. Last accessed 15 May 2021."},{"issue":"5","key":"1051_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1473-3099(01)00145-1","volume":"1","author":"MJ Bonten","year":"2001","unstructured":"Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis. 2001;1(5):314\u201325.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1051_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jiph.2016.04.010","volume":"10","author":"L Fossi Djembi","year":"2017","unstructured":"Fossi Djembi L, Hodille E, Chomat-Jaboulay S, Coudrais S, De Santis N, Gardes S, et al. Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak. J Infect Public Health. 2017;10(2):185\u201390.","journal-title":"J Infect Public Health"},{"issue":"6","key":"1051_CR7","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1128\/AAC.46.6.1619-1628.2002","volume":"46","author":"S Harbarth","year":"2002","unstructured":"Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2002;46(6):1619\u201328.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1051_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1086\/587647","volume":"29","author":"CN Olivier","year":"2008","unstructured":"Olivier CN, Blake RK, Steed LL, Salgado CD. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol. 2008;29(5):404\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1051_CR9","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/j.jhin.2018.02.016","volume":"100","author":"FNJ Frakking","year":"2018","unstructured":"Frakking FNJ, Bril WS, Sinnige JC, Klooster JEV, de Jong BAW, van Hannen EJ, et al. Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting. J Hosp Infect. 2018;100:e216\u201325.","journal-title":"J Hosp Infect"},{"issue":"5","key":"1051_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1086\/587187","volume":"29","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Moore C, Eden S, Tong A, McGeer A, Team MSHIC. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital. Infect Control Hosp Epidemiol. 2008;29(5):398\u2013403.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1051_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1128\/AAC.49.1.77-81.2005","volume":"49","author":"SA Ballard","year":"2005","unstructured":"Ballard SA, Grabsch EA, Johnson PD, Grayson ML. Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother. 2005;49(1):77\u201381.","journal-title":"Antimicrob Agents Chemother"},{"key":"1051_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13756-019-0466-x","volume":"8","author":"N Buetti","year":"2019","unstructured":"Buetti N, Wassilew N, Rion V, Senn L, Gardiol C, Widmer A, et al. Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey. Antimicrob Resist Infect Control. 2019;8:16.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhin.2021.07.002","volume":"116","author":"AC B\u00fcchler","year":"2021","unstructured":"B\u00fcchler AC, Dangel M, Frei R, J\u00e4ger S, Roth JA, Seth-Smith HMB, et al. Does high adherence to contact precautions lead to low in-hospital transmission of multidrug-resistant microorganisms in the endemic setting? J Hosp Infect. 2021;116:53\u20139.","journal-title":"J Hosp Infect"},{"issue":"1","key":"1051_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2047-2994-1-9","volume":"1","author":"S Fournier","year":"2012","unstructured":"Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control. 2012;1(1):9.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"43","key":"1051_CR15","first-page":"725","volume":"110","author":"NT Mutters","year":"2013","unstructured":"Mutters NT, Mersch-Sundermann V, Mutters R, Brandt C, Schneider-Brachert W, Frank U. Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance. Dtsch Arztebl Int. 2013;110(43):725\u201331.","journal-title":"Dtsch Arztebl Int"},{"issue":"5\u20136","key":"1051_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s15010-005-5079-z","volume":"33","author":"MF Kluytmans-Vandenbergh","year":"2005","unstructured":"Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005;33(5\u20136):309\u201313.","journal-title":"Infection"},{"key":"1051_CR17","unstructured":"Swissnoso. Eind\u00e4mmung der Verbreitung von Vancomycin-resistenten Enterokokken (VRE) in der Schweiz. Aktualisierung der nationalen Empfehlungen, Version 2.0 (Dezember 2019). Verf\u00fcgbar unter. https:\/\/www.swissnoso.ch\/forschung-entwicklung\/mdro-richtlinien\/vre."},{"key":"1051_CR18","unstructured":"Swissnoso. Maitriser la propagation des ent\u00e9rocoques r\u00e9sistants \u00e0 la vancomycine (VRE) en Suisse: mise \u00e0 recommnedations nationales. Version 2.0 (D\u00e9cembre 2019). https:\/\/www.swissnoso.ch\/fr\/recherche-developpement\/recommandations-bmr\/vre."},{"issue":"383","key":"1051_CR19","first-page":"890","volume":"9","author":"L Senn","year":"2013","unstructured":"Senn L, Petignant C, Chabanel D, Zanetti G. Control of an outbreak of vancomycin-resistant enterococci in several hospitals of western Switzerland. Rev Med Suisse. 2013;9(383):890\u20133.","journal-title":"Rev Med Suisse"},{"key":"1051_CR20","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Pr\u00e9vention de la transmission crois\u00e9e des Bact\u00e9ries Hautement R\u00e9sistantes aux antibiotiques \u00e9mergentes (BHRe). 2013. http:\/\/www.cpias-ile-de-france.fr\/appui\/bhre.php. Last accessed 15 May 2021."},{"key":"1051_CR21","unstructured":"Schweizerisches Zentrum f\u00fcr Antibiotikaresistenzen. Institut f\u00fcr Infektionskrankheiten Universit\u00e4t Bern, Switzerland. http:\/\/www.anresis.ch\/."},{"issue":"12","key":"1051_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","volume":"25","author":"G Ogrinc","year":"2016","unstructured":"Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986\u201392.","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"1051_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135\u201360.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"1051_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jclinepi.2009.06.001","volume":"63","author":"MW Smith","year":"2010","unstructured":"Smith MW, Ma J, Stafford RS. Bar charts enhance Bland\u2013Altman plots when value ranges are limited. J Clin Epidemiol. 2010;63(2):180\u20134.","journal-title":"J Clin Epidemiol"},{"key":"1051_CR25","unstructured":"https:\/\/www.bag.admin.ch\/bag\/de\/home\/zahlen-und-statistiken\/zahlen-fakten-zu-spitaelern\/kennzahlen-der-schweizer-spitaeler.html. Last accessed 10 July 2021."},{"issue":"7","key":"1051_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00103-016-2373-0","volume":"59","author":"S Hansen","year":"2016","unstructured":"Hansen S, Schwab F, Gropmann A, Behnke M, Gastmeier P, Consortium P. Infection control and safety culture in German hospitals. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;59(7):908\u201315.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1051_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13756-018-0366-5","volume":"7","author":"DV Gysin","year":"2018","unstructured":"Gysin DV, Cookson B, Saenz H, Dettenkofer M, Widmer AF, ESGfNI. Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey. Antimicrob Resist Infect Control. 2018;7:81.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"1051_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jac\/dkt525","volume":"69","author":"G De Angelis","year":"2014","unstructured":"De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(5):1185\u201392.","journal-title":"J Antimicrob Chemother"},{"key":"1051_CR29","doi-asserted-by":"publisher","first-page":"100732","DOI":"10.1016\/j.drup.2020.100732","volume":"53","author":"G Werner","year":"2020","unstructured":"Werner G, Neumann B, Weber RE, Kresken M, Wendt C, Bender JK, et al. Thirty years of VRE in Germany\u2014\u201cexpect the unexpected\u201d: the view from the National Reference Centre for Staphylococci and Enterococci. Drug Resist Update. 2020;53:100732.","journal-title":"Drug Resist Update"},{"key":"1051_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13756-018-0353-x","volume":"7","author":"C Remschmidt","year":"2018","unstructured":"Remschmidt C, Schroder C, Behnke M, Gastmeier P, Geffers C, Kramer TS. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany\u201410 years of surveillance. Antimicrob Resist Infect Control. 2018;7:54.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"1051_CR31","doi-asserted-by":"publisher","first-page":"e00412","DOI":"10.1128\/mBio.00412-13","volume":"4","author":"BP Howden","year":"2013","unstructured":"Howden BP, Holt KE, Lam MM, Seemann T, Ballard S, Coombs GW, et al. Genomic insights to control the emergence of vancomycin-resistant enterococci. MBio. 2013;4(4):e00412-e413.","journal-title":"MBio"},{"key":"1051_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13756-018-0335-z","volume":"7","author":"AA Mahony","year":"2018","unstructured":"Mahony AA, Buultjens AH, Ballard SA, Grabsch EA, Xie S, Seemann T, et al. Vancomycin-resistant Enterococcus faecium sequence type 796\u2014rapid international dissemination of a new epidemic clone. Antimicrob Resist Infect Control. 2018;7:44.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"1051_CR33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cmi.2018.09.017","volume":"25","author":"A Nutman","year":"2019","unstructured":"Nutman A, Marchaim D. How to: molecular investigation of a hospital outbreak. Clin Microbiol Infect. 2019;25(6):688\u201395.","journal-title":"Clin Microbiol Infect"},{"key":"1051_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13756-019-0604-5","volume":"8","author":"VA Janes","year":"2019","unstructured":"Janes VA, Notermans DW, Spijkerman IJB, Visser CE, Jakobs ME, van Houdt R, et al. Amplified fragment length polymorphism and whole genome sequencing: a comparison of methods in the investigation of a nosocomial outbreak with vancomycin resistant enterococci. Antimicrob Resist Infect Control. 2019;8:153.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"6","key":"1051_CR35","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10096-019-03524-z","volume":"38","author":"MHH Abdelbary","year":"2019","unstructured":"Abdelbary MHH, Senn L, Greub G, Chaillou G, Moulin E, Blanc DS. Whole-genome sequencing revealed independent emergence of vancomycin-resistant Enterococcus faecium causing sequential outbreaks over 3 years in a tertiary care hospital. Eur J Clin Microbiol Infect Dis. 2019;38(6):1163\u201370.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1051_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jhin.2020.05.013","volume":"105","author":"SA Egan","year":"2020","unstructured":"Egan SA, Corcoran S, McDermott H, Fitzpatrick M, Hoyne A, McCormack O, et al. Hospital outbreak of linezolid-resistant and vancomycin-resistant ST80 Enterococcus faecium harbouring an optrA-encoding conjugative plasmid investigated by whole-genome sequencing. J Hosp Infect. 2020;105(4):726\u201335.","journal-title":"J Hosp Infect"},{"issue":"9","key":"1051_CR37","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/jac\/dkv142","volume":"70","author":"M Pinholt","year":"2015","unstructured":"Pinholt M, Larner-Svensson H, Littauer P, Moser CE, Pedersen M, Lemming LE, et al. Multiple hospital outbreaks of vanA Enterococcus faecium in Denmark, 2012\u201313, investigated by WGS, MLST and PFGE. J Antimicrob Chemother. 2015;70(9):2474\u201382.","journal-title":"J Antimicrob Chemother"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01051-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:23:42Z","timestamp":1643369022000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01051-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01051-9","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed as quality improvement project that does not require approval by the ethics committee as it did not involve individual patient data or patient groups.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"In this study, no individually identifiable data are included. All data are presented as pooled data. As such, consent for publication was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}